Literature DB >> 6975347

T cell growth factor receptors. Quantitation, specificity, and biological relevance.

R J Robb, A Munck, K A Smith.   

Abstract

To examine directly the hypothesis that T cell growth factor (TCGF) interacts with target cells in a fashion similar to polypeptide hormones, the binding of radiolabeled TCGF to various cell populations was investigated. The results indicate that TCGF interacts with activated T cells via a receptor through which it initiates the T cell proliferative response. Internally radiolabeled TCGF, prepared from a human T leukemia cell line and purified by gel filtration and isoelectric focusing, retained biological activity and was uniform with respect to size and charge. Binding of radiolabeled TCGF to TCGF-dependent cytolytic T cells occurred rapidly (within 15 rain at 37 degrees C) and was both saturable and largely reversible. In addition, at 37 degrees C, a receptor- and lysosome-dependent degradation of TCGF occurred. Radiolabeled TCGF binding was specific for activated, TCGF-responsive T cells. Whereas unstimulated lymphocytes of human or murine origin and lipopolysaccharide-activated B cell blasts expressed few if any detectable binding sites, lectin- or alloantigen-activated cells had easily detectable binding sites. Moreover, compared with lectin- or alloantigen-activated T cells, long-term TCGF-dependent cytolytic and helper T cell lines and TCGF-dependent neo-plastic T cell lines bound TCGF with a similar affinity (dissociation constant of 5-25 pM) and expressed a similar number of receptor sites per cell (5,000-15,000). In contrast, a number of TCGF-independent cell lines of T cell, B cell, or myeloid origin did not bind detectable quantities of radiolabeled TCGF. Binding of radiolabeled TCGF to TCGF-responsive cells was specific, in that among several growth factors and polypeptide hormones tested, only TCGF competed for binding. Finally, the relative magnitude of T cell proliferation induced by a given concentration of TCGF closely paralleled the fraction of occupied receptor sites. As the extent of T cell clonal expansion depends on TCGF and on the TCGF receptor, the dissection of the molecular events surrounding the interaction of TCGF and its receptor that these studies permit, should provide new insight into the hormonelike regulation of the immune response by this lymphokine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975347      PMCID: PMC2186509          DOI: 10.1084/jem.154.5.1455

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  41 in total

1.  A permanent human cytotoxic T-cell line with high killing capacity against a lymphoblastoid B-cell line shows preference for HLA A, B target antigens and lacks spontaneous cytotoxic activity.

Authors:  H Spits; J E de Vries; C Terhorst
Journal:  Cell Immunol       Date:  1981-04       Impact factor: 4.868

2.  Polypeptide hormone degradation and receptor regulation are coupled to ligand internalization. A direct biochemical and morphologic demonstration.

Authors:  N Hizuka; P Gorden; M A Lesniak; E Van Obberghen; J L Carpentier; L Orci
Journal:  J Biol Chem       Date:  1981-05-10       Impact factor: 5.157

3.  Functional and molecular characteristics of T-cell growth factor.

Authors:  K A Smith; P E Baker; S Gillis; F W Ruscetti
Journal:  Mol Immunol       Date:  1980-05       Impact factor: 4.407

4.  Lymphocyte activating factor promotes T-cell growth factor production by cloned murine lymphoma cells.

Authors:  K A Smith; K J Gilbride; M F Favata
Journal:  Nature       Date:  1980-10-30       Impact factor: 49.962

Review 5.  Interleukin 2: a class of T cell growth factors.

Authors:  J Watson; D Mochizuki
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

6.  On the mechanism of ligand-induced down-regulation of insulin receptor level in the liver cell.

Authors:  M Krupp; M D Lane
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

Review 7.  Clones of killer and helper T cells: growth requirements, specificity and retention of function in long-term culture.

Authors:  M H Schreier; N N Iscove; R Tees; L Aarden; H von Boehmer
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

8.  Culture supernatants of a stimulated T-cell line have helper activity that acts synergistically with interleukin 2 in the response of B cells to antigen.

Authors:  S L Swain; G Dennert; J F Warner; R W Dutton
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

9.  Mechanism of T cell activation. II. Antigen- and lectin-dependent acquisition of responsiveness to TCGF is a nonmitogenic, active response of resting T cells.

Authors:  E L Larsson
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

10.  Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.

Authors:  S Gillis; J Watson
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  271 in total

1.  cDNA cloning of ovine interleukin 2 by PCR.

Authors:  J C Goodall; D C Emery; A C Perry; L S English; L Hall
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

2.  Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells.

Authors:  J H Kehrl; M Dukovich; G Whalen; P Katz; A S Fauci; W C Greene
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

3.  Abnormal intracellular sorting of O-linked carbohydrate-deficient interleukin-2 receptors.

Authors:  K F Kozarsky; S M Call; S K Dower; M Krieger
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

4.  Regulation of 4F2 heavy-chain gene expression during normal human T-cell activation can be mediated by multiple distinct molecular mechanisms.

Authors:  T Lindsten; C H June; C B Thompson; J M Leiden
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

5.  Spontaneous recovery of the decreased expression in vitro of interleukin 2 receptors in rheumatoid arthritis.

Authors:  C Plater-Zyberk; K A Rockett; R N Maini
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

6.  Interleukin 2 receptor bearing T lymphocytes in patients with chronic liver disease.

Authors:  S Kakumu; K Yoshioka; A Fuji; H Tahara
Journal:  Gastroenterol Jpn       Date:  1988-08

7.  5-Lipoxygenase activity increases susceptibility to experimental Paracoccidioides brasiliensis infection.

Authors:  Fabrine Sales Massafera Tristão; Fernanda Agostini Rocha; Ana Paula Moreira; Fernando Queiroz Cunha; Marcos Antonio Rossi; João Santana Silva
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

8.  Antigenic stimulation regulates the level of expression of interleukin 2 receptor on human T cells.

Authors:  M E Hemler; M B Brenner; J M McLean; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

Review 9.  Receptor-directed therapy of T-cell leukemias and lymphomas.

Authors:  John C Morris; Thomas A Waldmann; John E Janik
Journal:  J Immunotoxicol       Date:  2008-04       Impact factor: 3.000

10.  Antibodies of predetermined specificity against chemically synthesized peptides of human interleukin 2.

Authors:  A Altman; J M Cardenas; R A Houghten; F J Dixon; A N Theofilopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.